Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients
Clinical trial NCT02532764 · COMPLETED
Trial details
- NCT number
- NCT02532764
- Sponsor
- ProQR Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-09-14
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.